Property:Exclusion criteria
This is a property of type Text.
M
Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization +
NA +
N
Najafizade et al. (2013): Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial +
Oral candidiasis or other oral lesions (e.g., stomatitis, necrosis, and ulcers), cranial nerve injuries, and metabolic/endocrine disorders that may have effects on taste perception +
Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients +
Scleroderma, large breast with an inter-field of more than 25cm, or prior radiotherapy to the same breast, indication to lymph node irradiation +
Newling et al. (1995): Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group +
Patients receiving chronic medication with salicylate derivatives, oestrogens, sulphonamides, isoniazid and steroids +
Ng et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial +
Receiving prior treatment for advanced or metastatic disease; taking 2000 IU/d or greater of vitamin D<sub>3</sub>, had symptomatic genitourinary stones within the past year, or were taking thiazide diuretics. +
Nguyen et al. (2012): Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities +
Drank tea regularly within 1 month of enrollment (more than 6 servings of hot tea or 12 servings of iced tea or equivalent combination per week); receiving other investigational agents; history of allergic reactions attributed to compounds of similar chemical to polyphenon E; uncontrolled intercurrent illness +
Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia +
Aromatase inhibitor therapy in the last 6 weeks, history of kidney stones, hypercalcemia at baseline, history of symptomatic hypercalcemia or hyperparathyroidism, baseline 25-OH Vitamin D level >50 ng/mL, currently taking phenytoin or phenobarbital, currently taking cholestyramine or orlistat, malabsorption syndrome, or chronic granulomata forming disorders, such as sarcoidosis or tuberculosis +
O
Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients +
* Previous liver surgery.
* Body weight loss >10% during the 6 months before surgery.
* Presence of distant metastases.
* Seriously impaired function of vital organs due to respiratory, renal, or heart disease.
* Biliary cancer, due to the need for biliary resection, bilioenteric anastomosis, and lymphadenectomy during hepatectomy for this condition.
+
Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy +
Radiotherapy of the brain or for gynaecological cancers +
Ota et al. (2014): The effect of pyridoxine for prevention of hand-foot-syndrome in colorectal cancer patients with adjuvant chemotherapy using capecitabine: A randomized study +
Pregnant or lactating, or planning to become pregnant; history of hypersensitivity or severe adverse reaction to fluoropyrimidines; serious concurrent disease (including interstitial pneumonia, pulmonary fibrosis, intestinal paralysis, ileus, poorly controlled diabetes, liver cirrhosis or hepatitis (type B or C), poorly controlled hypertension, history of myocardial infarction or unstable angina within past 6 months); active multiple primary cancer (disease-free less than 5 years); concurrent infectious disease; judged to be unsuitable for participation in the clinical study by the investigator for any other reason +
P
Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy +
Previous chemotherapeutic treatment or regimens including other neurotoxic drugs associated with cisplatin +
Previous chemotherapeutic treatment or regimens including other neurotoxic drugs associated with cisplatin +
Panahi et al. (2012): Effect of Ginger on Acute and Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot, Randomized, Open-Label Clinical Trial +
Participation in another study with different drugs; history of bone marrow or stem cell transplantation; presence of respiratory, cardiovascular, liver, renal, metabolic, or gastrointestinal diseases; and history of motion sickness +
Paur et al. (2017): Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA +
White blood cells outside normal reference window; Hb < 11 g/dL; prior endocrine treatment; <5 year life-expectancy; ECOG score >1; incontinence/urinary retention; critical comorbidity (e.g. cardiovascular disease, chronic obstructive pulmonary disease, insulin dependent diabetes mellitus, vasculitis, inflammatory bowel syndrome or other conditions with potential influence on radiation therapy) +
Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial +
Patients receiving long-term methadone therapy for pain; major psychiatric or cardiovascular disorder; epilepsy; significant renal or hepatic impairment; pregnant, lactating or not using adequate contraception; patients, who had received or who were due to receive therapies expected to change the pain (such as radiotherapy, or chemotherapy or hormonal therapy); marijuana use, cannabinoid-based medications or rimonabant within 30 days of study entry, and unwilling to abstain for the duration of the study +
Puataweepong et. al (2009): The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study +
Previous radiotherapy; allergies to aloe; diabetes mellitus; HIV +
R
Raei et al. (2013): Effect of herbal therapy to intensity chemotherapy-induced nausea and vomiting in cancer patients +
Corticosteroids, digestive problems, anticoagulation, radiotherapy +
Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study +
Infected tooth, ulcers, or mucositis of the oral cavity +
Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial +
With baseline serum corrected total calcium >10.5 mg/dl, phosphorous >4.5 mg/dl, magnesium >2.5 mg/dl, nephrolithiasis in the past 5 years, calcitriol therapy in the previous 30 days, hypersensitivity or inability to take oral calcitriol +